Influence of an Extremely NegatiWely Charged Porphyrin
product, as well as the NO binding and dissociation rate
constants. The reactivity of iron porphyrins is finely regulated
by a variety of structural and electronic features, for example,
the nature of the axial ligands, the type of substituents on
the porphyrin periphery, the polarity of the reaction medium,
and other factors. To investigate the role of these factors,
numerous spectroscopic, structural, and mechanistic studies
are reported on the interaction of NO with synthetic model
complexes.3
ferric porphyrins such as TPPS (tetra-(4-sulfonatophenyl)-
porphyrinato), TMPyP (meso-tetrakis(N-methyl-4-pyridyl)
porphyrinato),6,16,17 P8+ (5,10,15,20-tetrakis-(4′-t-butyl-
2′,6′-bis(4-t-butylpyridine)phenyl)-porphyrinato),18
and
P
8- (54,104,154,204-tetra-t-butyl-52,56,152,156-tetrakis-(2,2-bis-
carboxylato-ethyl)-5,10,15,20-tetraphenylporphyrinato)18 were
systematically studied in aqueous medium, in which the
resulting nitrosyl adducts ((P)FeIII + NO f (P)FeII-NO+)
-
interact with a nucleophile, namely, OH- and NO2 , to yield
Mechanistic studies on the reactions of NO with heme
proteins or model ferric porphyrins have been performed by
the application of laser flash photolysis and stopped-flow
techniques. Studies on the reversible binding of NO to
synthetic iron(II) and iron(III) porphyrins4,5 and iron(III)
heme proteins,6a,7-10 such as cytochrome P450 and met-
myoglobin, have been performed in which distinctive features
of the active site of heme proteins were used to develop
useful biomimetic model systems.
The binding of NO to an oxidizing metal (Mn+) induces
intramolecular electron transfer, leading to the formation of
(P)M(n-1)+-NO+, followed by nitrosylation of a nucleophile
(Nu-) to produce (P)M(n-1)+ and Nu--NO+. The observed
reaction involves reductive nitrosylation as expressed in
reaction 1. Recent reports have supported that reductive
nitrosylation is proposed as a viable pathway in which
hemoglobin binds NO to the cys â-93 residue and forms
S-nitrosohemoglobin in the transport and metabolism of
NO.11,12
ferroheme proteins. Recent studies performed in our labo-
ratories clearly revealed that the observed rate constant for
NO reduction depends on the concentration of NO and OH-
and suggested that the porphyrin environment involving
oppositely charged substituents has a crucial influence on
the observed rate constants and mechanistic features of
nitrite-catalyzed reductive nitrosylation.18
The goal of these investigations is to understand the
influence of the iron porphyrin microenvironment on the
reactivity with NO and the stability of the resulting (P)FeII-
(NO+) species toward subsequent reaction in aqueous solu-
tion. In this context, the reported studies were undertaken
to investigate the systematic influence of the porphyrin
environment on the properties and reactivity of water-soluble
ferric porphyrins.3-7 We now report the synthesis and
spectroscopic characterization of an extremely negatively
charged iron(III) porphyrin, (P16-)FeIII(L)2 (hexadecasodium
iron 54,104,154,204-tetra-t-butyl-52,56,102,106,152,156,202,206-
octakis[2,2-bis(carboxylato)ethyl)]-5,10,15,20-tetraphenylpor-
phyrin) (Figure 1), and evaluate the detailed kinetics of its
interaction with NO. In the latter context, variable pH-,
temperature-, and pressure-dependent stopped-flow measure-
ments provided a detailed kinetic and mechanistic description
of the reversible binding of NO to (P16-)FeIII(H2O)2 and
(P16-)FeIII(OH) present in aqueous solution at low and high
(P)Mn+ + NO {KNO} (P)M(n-1)+- NO+
-8
+Nu
(P)M(n-1)+ + Nu--NO+ (1)
On the basis of spectroscopic and kinetic data, the NO
reduction of ferric-heme proteins (viz., ferric cytochrome c,
metmyoglobin, and methemoglobin)13-15 and synthetic model
(9) (a) Frank, A.; Jung, C.; van Eldik, R. J. Am. Chem. Soc. 2004, 126,
4181. (b) Suzuki, N.; Higuchi, T.; Urano, Y.; Kikuhchi, K.; Uchida,
T.; Mukai, M.; Kitagawa, T.; Nagano, T. J. Am. Chem. Soc. 2000,
122, 12059. (c) Rich, A. M.; Armstrong, R. S.; Ellis, P. J.; Lay, P. A.
J. Am. Chem. Soc. 1998, 120, 10827.
(10) Newman, K. E.; Meyer, F. K.; Merbach, A. E. J. Am. Chem. Soc.
1979, 101, 1470.
(11) Gladwin, M. T.; Ognibene, F. P.; Pannell, L. K.; Nochols, J. S.; Pease-
Fye, M. E.; Shelhamer, J. H.; Schechter, A. N. Free Radical Res.
2000, 97, 9943.
(12) (a) Weichsel, A.; Maes, E. M.; Andersen, J. F.; Valenzuela, J. G.;
Shokhireva, T. K.; Walker, F. A.; Montfort, W. R. Proc. Natl. Acad.
Sci. U.S.A. 2005, 102, 594. (b) Gladwin, M. T.; Lancaster, J. R., Jr.;
Freeman, B. A.; Schechter, A. N. Nat. Med. 2003, 9, 496. (c)
Luchsinger, B. P.; Rich, E. N.; Gow, A. J.; Williams, E. M.; Stamler,
J. S.; Singel, D. J. Proc. Natl. Acad. Sci. U.S.A. 2003, 100, 461. (e)
Stamler, J. S.; Jia, L.; Eu, J. P.; Mcmahon, T. J.; Demchenko, I. T.;
Bonaventura, J.; Gernert, K.; Piantadosi, C. A. Science 1997, 276,
2034. (f) Stamler, J. S.; Simon, D. I.; Osborne, J. A.; Mullins, M. E.;
Jaraki, O.; Michel, T.; Singel, D. J.; Loscalzo, J. Proc. Natl. Acad.
Sci. U.S.A. 1992, 89, 444. (g) Tran, D.; Skelton, B. W.; White, A. H.;
Lavermann, L. E.; Ford, P. C. Inorg. Chem. 1998, 37, 2505.
(13) Yoshimura, T.; Suzuki, S.; Nakahara, A.; Iwasaki, H.; Masuko, M.;
Matsubara, T. Biochim. Biophys. Acta. 1985, 831, 267.
(14) (a) Gow, A. J.; Luchsinger, B. P.; Pawloski, J. R.; Singel, D. J.;
Stamler, J. S. Proc. Natl. Acad. Sci. U.S.A. 1999, 96, 9027. (b) Chien,
J. C. W. J. Am. Chem. Soc. 1969, 91, 2166.
(15) Yoshimura, T.; Suzuki, S. Inorg. Chim. Acta. 1988, 152, 241.
(16) Tran, D.; Skelton, B. W.; White, A. H.; Lavermann, L. E.; Ford, P.
C. Inorg. Chem. 1998, 37, 2505.
(2) (a) Bredt, D. S.; Hwang, P. M.; Glatt, C. E.; Lowenstein, C.; Reed,
R. R.; Snyder, S. H. Nature (London) 1991, 351, 714. (b) Steven, P.
S.; Lewis, C. B.; David, A. K.; Hunter, C. C.; Michael, L. T.; Sandra,
F.; Kavita, V. E.; Mark, D. K.; Susan, N. T.; Anne, C.; Joshua, H.;
Gary, G. J. Am. Med. Assoc. 2006, 295, 58. (c) Moncada, S.; Palmer,
R. M.; Higgs, E. A. Biochem. Pharmacol. 1989, 38, 1709. (d) Hibbs,
J. B., Jr.; Tainter, R. R.; Vabrin, Z. Science. 1987, 235, 473.
(3) (a) Ford, P. C.; Laverman, L. E.; Lorkovic, I. M. AdV. Inorg. Chem.
2003, 54, 2003. (b) Ford, P. C.; Lorkovic, I. M. Chem. ReV. 2002,
102, 993, and references therein. (c) Hoshino, M.; Laverman, L. E.;
Ford, P. C. Coord. Chem. ReV. 1999, 187, 75. (d) Laverman, L. E.;
Ford, P. C. J. Am. Chem. Soc. 2001, 123, 11614. (e) Ford, P. C.;
Fernandez, B. O.; Lim, M. D. Chem. ReV. 2005, 105, 2439. (f)
Meunier, B. Chem. ReV. 1992, 92, 1411.
(4) (a) Wolak, M.; van Eldik, R. J. Am. Chem. Soc. 2005, 127, 13312
and references cited therein.
(5) (a) Jee, J.-E.; Eigler, S.; Hampel, F.; Jux, N.; Wolak, M.; Zahl, A.;
Stochel, G.; van Eldik, R. Inorg. Chem. 2005, 44, 7717. (b) Jee, J.-
E.; Wolak, M.; Balbinot, D.; Jux, N.; Zahl, A.; van Eldik, R. Inorg.
Chem. 2006, 45, 1326 and references cited therein.
(6) (a) Theodoridis, A.; van Eldik, R. J. Mol. Catal. A. 2004, 24, 197. (b)
Trofimova, N. S.; Safronov, A. Y.; Ikeda, S. Inorg. Chem. 2003, 42,
1945. (c) Hoshino, M.; Maeda, M.; Konishi, R.; Seki, H.; Ford, P. C.
J. Am. Chem. Soc. 1996, 118, 5702.
(7) (a) Franke, A.; Stochel, G.; Suzuki, N.; Higuchi, T.; Okuzono, K.;
van Eldik, R. J. Am. Chem. Soc. 2005, 127, 5360. (b) Wolak, M.; van
Eldik, R. Coord. Chem. ReV. 2003, 230, 263. (c) Schneppensieper,
T.; Zahl, A.; van Eldik, R. Angew. Chem., Int. Ed. 2001, 40, 1678.
(8) (a) Wyllie, G. R. A.; Scheidt, W. R. Chem. ReV. 2002, 102, 1067. (b)
Ellison, M. K.; Schulz, Chapter E.; Scheidt, R. W. J. Am. Chem. Soc.
2002, 124, 13833.
(17) Fernandez, B. O.; Lorkobic, I. M.; Ford, P. C. Inorg. Chem. 2004,
43, 5393.
(18) Jee, J.-E.; van Eldik, R. Inorg. Chem. 2006, 45, 6523.
Inorganic Chemistry, Vol. 46, No. 8, 2007 3337